Please reach out to our team if you have questions about which injection is best suited for your needs, or to set up your personalized treatment schedule
Expertise & Skills Specialized on device management solutions Best Awards Microsoft Certified Engineer MY HISTORY Education & Experience EDUCATION 2009 - 2012 3o Agiou Dimitriou EDUCATION 2012 - 2016 Bachelor's degree, Computer Engineering Arta City, Technological Institute of Epirus EXPERIENCE 2016 - 2016 Computer Technician Arta City, Tatsis Center S.A EXPERIENCE 2018 - 2020 Senior Infrastructure Engineer Athens City, InTTrust S.A EXPERIENCE 2018 - 2018 Sales And Service Agent Athens City, Germanos S.A EXPERIENCE 2020 - Present Senior System Administrator Athens City, OTE Group of Companies (HTO) EXPERTISE Achievements Microsoft Certified Trainer Microsoft Certified Solution Associate Windows Server 2016 Azure Fundamentals Azure Administrator Associate Security, Compliance And Identity Fundamentals Azure Solutions Architect Expert Microsoft 365 Certified : Endpoint Administrator Azure Virtual Desktop On-Premise Services Active Directory MECM DHCP Print Servers File Servers Microsoft SQL Server PowerBI Operating Systems Windows Servers Windows 10 & 11 Linux MacOS Cloud Services Azure Microsoft 365 Intune Azure Virtual Desktops Azure SQL Azure Active Directory Security Microsoft 365 Defender Microsoft Defender for Cloud Trend Micro Symantec MY TECH BLOG Latest Posts July 21, 2023 How to Migrate Print Server More and more people are migrating from traditional print server to a cloud-hosted printer server. July 21, 2023 How to Migrate DHCP Server Migrating the DHCP service from the old server to the new Windows Server 2016/2019/2022 host
Chronic hyperglycemia accelerates all complications via oxidative stress, advanced glycation end products (AGEs), and the polyol pathway
It's studied for mobilizing stored fat (lipolysis) and blocking new fat storage (lipogenesis) through adipose-tissue pathways, without engaging appetite or insulin signaling
The lipolytic effects of a modified growth hormone fragment (AOD-9604). Regulatory Peptides
Twelve peptides that had been placed on the FDAs Category 2 restricted compounding list in 2023 are coming off that list effective April 23, 2026
